What Next

The Price of a Peanut Allergy

There are currently no FDA-approved treatments for peanut allergies. A new drug was just recommended for approval.

Illustration depicting a female with a microphone

Listen longer

Slate Plus members get ad-free versions of all Slate podcasts, plus extra segments, bonus episodes, and more. Try it free today.

Join Slate Plus

Episode Notes

A buzzy new drug to treat peanut allergies was recommended for approval by a Food and Drug Administration advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain why many prescription drugs are so expensive.

Guest: James Hamblin, staff writer at the Atlantic.

Podcast production by Mary Wilson, Jayson De Leon, Danielle Hewitt, and Mara Silvers.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

About the Show

The problem with the news right now? It’s everywhere. And each day, it can feel like we’re all just mindlessly scrolling. It’s why we created What Next. This short daily show is here to help you make sense of things. When the news feels overwhelming, we’re here to help you answer: What next? Look for new episodes every weekday morning.

All episodes

Host

  • Mary Harris is the host and managing editor of What Next, Slate's new daily news podcast. She has reported throughout the public radio system, for NPR, Marketplace, and WNYC.

Follow